Society for Immunotherapy of Cancer
health care
Based in WI
🤖
AI Overview
With $1.4M in lobbying spend across 32 quarterly filings, Society for Immunotherapy of Cancer is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.
$1.4M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $150K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $140K |
| 2025 | $130K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
- •Funding for cancer immunotherapy research at NIH and FDA
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.